Tocilizumab monotherapy improves bone mineral density as well as TNF blockers plus methotrexate with methotrexate-resistant active rheumatoid arthritis. An Open-lable randomized clinical trial. T-bone Trial - Kensuke, K; Amano, K; Yamada, S (Arthritis Rheum, 2011)
63 [10